placenta-derived MMSCs
/ Institute of Cell Therapy
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 08, 2020
Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs
(clinicaltrials.gov)
- P1/2; N=30; Recruiting; Sponsor: Institute of Cell Therapy
New P1/2 trial • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases • PCR
July 01, 2020
Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stromal Cells for Osteoarthritis
(clinicaltrials.gov)
- P1/2; N=45; Recruiting; Sponsor: Institute of Cell Therapy
Clinical • New P1/2 trial • Immunology • Osteoarthritis • Pain • Rheumatology
1 to 2
Of
2
Go to page
1